キッセイ薬品工業株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 日本マスタートラスト信託銀行株式会社 | 5,033,000 | 12.14% | ¥23.4B | ¥805M |
| 2 | 株式会社八十二長野銀行 | 2,063,000 | 4.98% | ¥9.6B | ¥330M |
| 3 | 株式会社日本カストディ銀行 | 1,840,000 | 4.44% | ¥8.5B | ¥294M |
| 4 | Kanazawa Ltd. | 1,678,000 | 4.05% | ¥7.8B | ¥268M |
| 5 | Rikuo Kamizawa | 1,550,000 | 3.74% | ¥7.2B | ¥248M |
| 6 | 第一生命保険株式会社 | 1,344,000 | 3.24% | ¥6.2B | ¥215M |
| 7 | Nabebayashi Co., Ltd. | 1,222,000 | 2.95% | ¥5.7B | ¥196M |
| 8 | キッセイグループ従業員持株会 | 1,212,000 | 2.93% | ¥5.6B | ¥194M |
| 9 | STATE STREET BANK AND TRUST COMPANY 505103 | 1,112,000 | 2.68% | ¥5.2B | ¥178M |
| 10 | Shionogi Pharmaceutical Co., Ltd. | 914,000 | 2.20% | ¥4.2B | ¥146M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Rikuo Kamizawa | Chairman & Representative Director, CEO | 1,550,567 | ¥7.2B | — |
| 竹花 泰雄 | President & Representative Director, COO | 21,062 | ¥97.8M | — |
| 福島 敬二 | Executive Vice President & Director | 15,728 | ¥73.0M | — |
| 高山 哲 | Senior Managing Director, CHRO | 18,529 | ¥86.0M | — |
| 北原 孝秀 | Managing Director, CFO | 11,777 | ¥54.7M | — |
| 降簱 喜男 | Director | 14,899 | ¥69.2M | — |
| 野明 浩史 | Director | 4,307 | ¥20.0M | — |
| 宮澤 敬治 | Director | 4,407 | ¥20.5M | — |
| 清水 重孝 | Director | 4,500 | ¥20.9M | — |
| 野村 稔 | Director | 6,300 | ¥29.2M | — |
| 内川 小百合 | Director | 2,500 | ¥11.6M | — |
| 大月 良則 | Director | 2,800 | ¥13.0M | — |
| 菊池 伸次 | Full-time Audit & Supervisory Board Member | 8,000 | ¥37.1M | — |
| 腰原 なおみ | Full-time Audit & Supervisory Board Member | 2,100 | ¥9.7M | — |
| 中川 寛道 | Audit & Supervisory Board Member | 3,600 | ¥16.7M | — |
| 岩渕 道男 | Audit & Supervisory Board Member | 1,100 | ¥5.1M | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥4,642 | ¥331.54 | 14.0x | ¥160.0 | 46,541,985 |
| FY ending Mar 2025 | ¥3,839 | ¥274.21 | 14.0x | ¥100.0 | 47,911,185 |
| FY ending Mar 2024 | ¥3,526 | ¥246.61 | 14.3x | ¥82.0 | 49,311,185 |
| FY ending Mar 2023 | ¥2,648 | ¥228.31 | 11.6x | ¥80.0 | 51,811,185 |